MedTrace Logo

A Prospective Observational Study of Adult Strabismus

NCT02510040 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 217

Last updated 2023-07-06

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to describe clinical characteristics, treatments, and one-year outcomes of adults with convergence insufficiency, divergence insufficiency, or small angle hypertropia.

Conditions

  • Convergence Insufficiency
  • Divergence Insufficiency
  • Hypertropia

Interventions

DEVICE

Prism

Ground-in or Fresnel prism

OTHER

Orthoptic Exercises

Orthoptic exercises- fusion, convergence, divergence, and others, including computer-based therapy

PROCEDURE

Eye Muscle Surgery

* Bilateral medial rectus muscle resection surgery * Single medial rectus muscle resection surgery * Recess lateral rectus muscle resection medial rectus muscle surgery * Bilateral lateral rectus muscle recession surgery * Single lateral rectus muscle recession surgery * Bilateral lateral rectus muscle resection surgery * Single lateral rectus muscle resection surgery * Recess medial rectus muscle resection lateral rectus muscle surgery * Bilateral medial rectus muscle recession surgery * Single medial rectus muscle recession surgery * Vertical rectus muscle recession surgery * Vertical rectus muscle mini-tenotomy (snip) surgery

PROCEDURE

Botox Injection

Botulinum toxin injection

Sponsors & Collaborators

  • Pediatric Eye Disease Investigator Group

    collaborator NETWORK

  • National Eye Institute (NEI)

    collaborator NIH

  • Jaeb Center for Health Research

    lead OTHER

Principal Investigators

  • Earl R Crouch, III, MD · Virginia Pediatric Eye Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-17
Primary Completion
2017-12-31
Completion
2019-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02510040 on ClinicalTrials.gov